Literature DB >> 1968381

Cloning of malignantly transformed rat thyroid (FRTL) cells with thyrotropin receptors and their growth inhibition by 3',5'-cyclic adenosine monophosphate.

T Endo1, H Shimura, T Saito, T Onaya.   

Abstract

Differentiated rat thyroid cells, designated FRTL, are totally dependent on TSH for their growth. We continuously cultured FRTL cells in the absence of TSH and found that another type of cell appeared in the culture. The new cells were large, flattened and epithelial-like, and none of them exhibited thyroglobulin immunoreactivity. Since they grew independently of TSH, we further cloned these mutated cells by the limited dilution method in the absence of TSH. cAMP production in the cloned cells (FRTL-Tc) was stimulated dose-dependently by TSH. The TSH concentration that produced a maximal level of cAMP in FRTL-Tc cells was 1 order of magnitude higher than in FRTL cells. A [125I]TSH binding study confirmed that the FRTL-Tc cells had TSH receptors with the same binding capacity but a higher Kd than those of FRTL cells. A [125I]cyanopindolol binding study revealed that the FRTL-Tc cells had acquired beta 2-adrenergic receptors and that isoproterenol or epinephrine could stimulate cAMP production in the cells. TSH or beta-adrenergic agonists inhibited the growth of these cells, as did (Bu)2cAMP. When FRTL-Tc cells were transplanted into the sc tissue in Fisher rats, they grew as a tumor in all of the animals (n = 10). Metastasis of the tumors to the lung and liver occurred. These results indicate that FRTL-Tc cells are malignantly transformed cells with TSH receptors derived from thyroid epithelial cells and also suggest that the role of cAMP in the proliferation of the transformed cells might be different from that in normal cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968381     DOI: 10.1210/endo-126-3-1492

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Morphology of FRTL-5 cell colonies in a semi-solid medium.

Authors:  Z Pajer; A Cör; D Stiblar-Martincic
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

2.  Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

Authors:  Toyoshi Endo; Tetsuro Kobayashi
Journal:  Endocr Relat Cancer       Date:  2013-10-14       Impact factor: 5.678

Review 3.  The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.

Authors:  Alan R Penheiter; Stephen J Russell; Stephanie K Carlson
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391

4.  Transplantable rat thyroid cancer cell line FRTC transformed with muramyl dipeptide.

Authors:  M Iitaka; N Fukasawa; S Kitahama; S Miura; Y Kawakami; H Sato; S Sugano; J Ishii; S Katayama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.